Cargando…

Cell Free DNA of Tumor Origin Induces a ‘Metastatic’ Expression Profile in HT-29 Cancer Cell Line

BACKGROUND: Epithelial cells in malignant conditions release DNA into the extracellular compartment. Cell free DNA of tumor origin may act as a ligand of DNA sensing mechanisms and mediate changes in epithelial-stromal interactions. AIMS: To evaluate and compare the potential autocrine and paracrine...

Descripción completa

Detalles Bibliográficos
Autores principales: Fűri, István, Kalmár, Alexandra, Wichmann, Barnabás, Spisák, Sándor, Schöller, Andrea, Barták, Barbara, Tulassay, Zsolt, Molnár, Béla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489610/
https://www.ncbi.nlm.nih.gov/pubmed/26133168
http://dx.doi.org/10.1371/journal.pone.0131699
_version_ 1782379384663965696
author Fűri, István
Kalmár, Alexandra
Wichmann, Barnabás
Spisák, Sándor
Schöller, Andrea
Barták, Barbara
Tulassay, Zsolt
Molnár, Béla
author_facet Fűri, István
Kalmár, Alexandra
Wichmann, Barnabás
Spisák, Sándor
Schöller, Andrea
Barták, Barbara
Tulassay, Zsolt
Molnár, Béla
author_sort Fűri, István
collection PubMed
description BACKGROUND: Epithelial cells in malignant conditions release DNA into the extracellular compartment. Cell free DNA of tumor origin may act as a ligand of DNA sensing mechanisms and mediate changes in epithelial-stromal interactions. AIMS: To evaluate and compare the potential autocrine and paracrine regulatory effect of normal and malignant epithelial cell-related DNA on TLR9 and STING mediated pathways in HT-29 human colorectal adenocarcinoma cells and normal fibroblasts. MATERIALS AND METHODS: DNA isolated from normal and tumorous colonic epithelia of fresh frozen surgically removed tissue samples was used for 24 and 6 hour treatment of HT-29 colon carcinoma and HDF-α fibroblast cells. Whole genome mRNA expression analysis and qRT-PCR was performed for the elements/members of TLR9 signaling pathway. Immunocytochemistry was performed for epithelial markers (i.e. CK20 and E-cadherin), DNA methyltransferase 3a (DNMT3a) and NFκB (for treated HDFα cells). RESULTS: Administration of tumor derived DNA on HT29 cells resulted in significant (p<0.05) mRNA level alteration in 118 genes (logFc≥1, p≤0.05), including overexpression of metallothionein genes (i.e. MT1H, MT1X, MT1P2, MT2A), metastasis-associated genes (i.e. TACSTD2, MACC1, MALAT1), tumor biomarker (CEACAM5), metabolic genes (i.e. INSIG1, LIPG), messenger molecule genes (i.e. DAPP, CREB3L2). Increased protein levels of CK20, E-cadherin, and DNMT3a was observed after tumor DNA treatment in HT-29 cells. Healthy DNA treatment affected mRNA expression of 613 genes (logFc≥1, p≤0.05), including increased expression of key adaptor molecules of TLR9 pathway (e.g. MYD88, IRAK2, NFκB, IL8, IL-1β), STING pathway (ADAR, IRF7, CXCL10, CASP1) and the FGF2 gene. CONCLUSIONS: DNA from tumorous colon epithelium, but not from the normal epithelial cells acts as a pro-metastatic factor to HT-29 cells through the overexpression of pro-metastatic genes through TLR9/MYD88 independent pathway. In contrast, DNA derived from healthy colonic epithelium induced TLR9 and STING signaling pathway in normal fibroblasts.
format Online
Article
Text
id pubmed-4489610
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44896102015-07-15 Cell Free DNA of Tumor Origin Induces a ‘Metastatic’ Expression Profile in HT-29 Cancer Cell Line Fűri, István Kalmár, Alexandra Wichmann, Barnabás Spisák, Sándor Schöller, Andrea Barták, Barbara Tulassay, Zsolt Molnár, Béla PLoS One Research Article BACKGROUND: Epithelial cells in malignant conditions release DNA into the extracellular compartment. Cell free DNA of tumor origin may act as a ligand of DNA sensing mechanisms and mediate changes in epithelial-stromal interactions. AIMS: To evaluate and compare the potential autocrine and paracrine regulatory effect of normal and malignant epithelial cell-related DNA on TLR9 and STING mediated pathways in HT-29 human colorectal adenocarcinoma cells and normal fibroblasts. MATERIALS AND METHODS: DNA isolated from normal and tumorous colonic epithelia of fresh frozen surgically removed tissue samples was used for 24 and 6 hour treatment of HT-29 colon carcinoma and HDF-α fibroblast cells. Whole genome mRNA expression analysis and qRT-PCR was performed for the elements/members of TLR9 signaling pathway. Immunocytochemistry was performed for epithelial markers (i.e. CK20 and E-cadherin), DNA methyltransferase 3a (DNMT3a) and NFκB (for treated HDFα cells). RESULTS: Administration of tumor derived DNA on HT29 cells resulted in significant (p<0.05) mRNA level alteration in 118 genes (logFc≥1, p≤0.05), including overexpression of metallothionein genes (i.e. MT1H, MT1X, MT1P2, MT2A), metastasis-associated genes (i.e. TACSTD2, MACC1, MALAT1), tumor biomarker (CEACAM5), metabolic genes (i.e. INSIG1, LIPG), messenger molecule genes (i.e. DAPP, CREB3L2). Increased protein levels of CK20, E-cadherin, and DNMT3a was observed after tumor DNA treatment in HT-29 cells. Healthy DNA treatment affected mRNA expression of 613 genes (logFc≥1, p≤0.05), including increased expression of key adaptor molecules of TLR9 pathway (e.g. MYD88, IRAK2, NFκB, IL8, IL-1β), STING pathway (ADAR, IRF7, CXCL10, CASP1) and the FGF2 gene. CONCLUSIONS: DNA from tumorous colon epithelium, but not from the normal epithelial cells acts as a pro-metastatic factor to HT-29 cells through the overexpression of pro-metastatic genes through TLR9/MYD88 independent pathway. In contrast, DNA derived from healthy colonic epithelium induced TLR9 and STING signaling pathway in normal fibroblasts. Public Library of Science 2015-07-02 /pmc/articles/PMC4489610/ /pubmed/26133168 http://dx.doi.org/10.1371/journal.pone.0131699 Text en © 2015 Fűri et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fűri, István
Kalmár, Alexandra
Wichmann, Barnabás
Spisák, Sándor
Schöller, Andrea
Barták, Barbara
Tulassay, Zsolt
Molnár, Béla
Cell Free DNA of Tumor Origin Induces a ‘Metastatic’ Expression Profile in HT-29 Cancer Cell Line
title Cell Free DNA of Tumor Origin Induces a ‘Metastatic’ Expression Profile in HT-29 Cancer Cell Line
title_full Cell Free DNA of Tumor Origin Induces a ‘Metastatic’ Expression Profile in HT-29 Cancer Cell Line
title_fullStr Cell Free DNA of Tumor Origin Induces a ‘Metastatic’ Expression Profile in HT-29 Cancer Cell Line
title_full_unstemmed Cell Free DNA of Tumor Origin Induces a ‘Metastatic’ Expression Profile in HT-29 Cancer Cell Line
title_short Cell Free DNA of Tumor Origin Induces a ‘Metastatic’ Expression Profile in HT-29 Cancer Cell Line
title_sort cell free dna of tumor origin induces a ‘metastatic’ expression profile in ht-29 cancer cell line
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489610/
https://www.ncbi.nlm.nih.gov/pubmed/26133168
http://dx.doi.org/10.1371/journal.pone.0131699
work_keys_str_mv AT furiistvan cellfreednaoftumororigininducesametastaticexpressionprofileinht29cancercellline
AT kalmaralexandra cellfreednaoftumororigininducesametastaticexpressionprofileinht29cancercellline
AT wichmannbarnabas cellfreednaoftumororigininducesametastaticexpressionprofileinht29cancercellline
AT spisaksandor cellfreednaoftumororigininducesametastaticexpressionprofileinht29cancercellline
AT schollerandrea cellfreednaoftumororigininducesametastaticexpressionprofileinht29cancercellline
AT bartakbarbara cellfreednaoftumororigininducesametastaticexpressionprofileinht29cancercellline
AT tulassayzsolt cellfreednaoftumororigininducesametastaticexpressionprofileinht29cancercellline
AT molnarbela cellfreednaoftumororigininducesametastaticexpressionprofileinht29cancercellline